ResearcherSichuan UniversityNo recent work listed
Zuowei Wu
Matched on OpenAlex author ID A5090828006. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers
Papers 6
- Simultaneous resection of oligometastatic pancreatic cancer: The 5-Year follow-up in a single center. Co-author DOI 10.1016/j.asjsur.2022.07.027↗
- Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltration in pancreatic cancer. Co-author DOI 10.5114/pjp.2023.134317↗
- Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single cen… Co-author DOI 10.3389/fonc.2022.966256↗
- Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection without preoperative neoadjuvant treatm… First author DOI 10.3389/fsurg.2022.992641↗
- EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. Co-author DOI 10.1097/md.0000000000027103↗
- Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. First author DOI 10.1186/s12893-020-00856-y↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bole Tian · 4 shared papers, 2020–2023 · strength 0.85
- Paper Simultaneous resection of oligometastatic pancreatic cancer: The 5-Year follow-up in a single center. DOI 10.1016/j.asjsur.2022.07.027↗
- Paper Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. DOI 10.1186/s12893-020-00856-y↗
- Paper Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection… DOI 10.3389/fsurg.2022.992641↗
- Li Mao · 3 shared papers, 2021–2023 · strength 0.51
- Paper Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltra… DOI 10.5114/pjp.2023.134317↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Chao Wu · 3 shared papers, 2020–2022 · strength 0.50
- Paper Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. DOI 10.1186/s12893-020-00856-y↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Xing Huang · 3 shared papers, 2021–2022 · strength 0.50
- Paper Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection… DOI 10.3389/fsurg.2022.992641↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Zihe Wang · 3 shared papers, 2021–2022 · strength 0.50
- Paper Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection… DOI 10.3389/fsurg.2022.992641↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- DuJiang Yang · 1 shared paper, 2023 · strength 0.19
- Qian Hu · 1 shared paper, 2023 · strength 0.19
- Huimin Lü · 1 shared paper, 2023 · strength 0.19
- Pengcheng Zhao · 1 shared paper, 2022 · strength 0.19
- Pengcheng Zhao · 1 shared paper, 2022 · strength 0.16
- Li Wang · 1 shared paper, 2022 · strength 0.16
- Bole Tian · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.